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The therapeutic value of liver has been known for some time.
Ligum (11) reported cases of anemia in infancy and childhood treated with
expressed juice of raw liver. Definite improvement occurred in all cases.
Faber (7) also used liver in severe anemias in infants and reported marked gains
in the hemoglobin and the number of red blood cells. Liver by mouth was also
recommended by Maurer et al. (12).
However, in view of the fact that oral administration of liver very often causes
gastrointestinal disturbances and is not well tolerated, especially when it is
given in large doses (pernicious anemia), the parenteral use of liver extract was
introduced and studied.
In 1929 Minot reported that a rapid remission in pernicious anemia could be
brought about by the parenteral use of liver extract. Very good results were also
reported by Murphy (16), Conjiery and Goldwater (3), Schaller and Newman
(31), and others. Liver extract given parenterally is now established as a stand-
ard treatment for pernicious anemia.
In view of the fact that following liver therapy there was noticed a prompt
and often striking increase in the leucocytes and blood platelets, Murphy (17)
suggested that liver extract parenterally might be valuable in those diseases
in which the number of blood elements is subnormal. Sharp (21) reports excellent
results in the use of liver in cases of anemia. Miller and Rhoades (15) report a
case of diarrhea of seven years' duration in which a complete cure was obtained
(sprue). Spiethof (24) in 1929 treated animals suering from arsphenamine
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toxicosis (emaciation, diarrhea, loss of appetite) with injections of liver extract.
All these animals improved, while the control subjects, which were not treated
with liver, died. Spiethof (25), Fuist and Felner (8) treated cases of arsphen-
amine dermatitis in human beings with liver extract injections and were gratified
with the results obtained. Fuist and Feilner (8) resorted to liver therapy also
in cases of arsphenamine intolerance without cutaneous manifestations and also
obtained good results. Stokes (26) advises the use of liver extract in arsphen-
amine dermatitis. On the other hand, Epstein (6) tried liver extract in cases of
arsphenamine dermatitis and found it unsatisfactory.
Hoffman (8) considers the dysfunction of liver as the main cause of araphen-
amine intolerance. Of the same opinion are also Milbradt (14) and Spiethof (24),
who believe that the liver's importance lies in its detoxifying ability. They
suggest that the injections of liver extract produce a hormonal influence on the
liver's function. As a result the liver begins to function normally and this factor
produces the improvement of the after effects of arsphenamine intolerance.
In view of the great importance of arsenical intolerance for
the future of affected syphilitic patients, I decided to investigate
the prophylactic and therapeutic value of liver extract in a group
of these cases.5.
Forty-eight cases were studied, of which 29 were females and 19 males. The
maximum age was 60, the minimum age 8. There were 29 cases from the Skin
and Cancer Unit of the New York Post-Graduate Hospital (service of Dr. Fred
Wise), 10 from the House of Detention for Women (service of Dr. Van Aletyne
Cornell), 5 from the syphilis clinic of the Metropolitan Hospital (service of Dr.
Frederic Dearborn), 2 from my private practice.
THE VALUE OF LIVER THERAPY IN THE PREVENTION OP
ARSENICAL INTOLERANCE
The results of Spiethof's experiments on animals convinced
him that liver can act as a curative agent in diseased states due
to arsphenamine intolerance. However, he did not think that
liver could be used'as a prophylactic agent in the above mentioned
cases. Sulzberger (27) in 1935 reported a case of pemphigus
which had shown a marked sensitivity to germanin. This
patient was given biweekly injections of liver extract intra-
muscularly together with biweekly injections of germanin. After
a few injections of liver the patient tolerated large doses of
In these studies the liver extract of Parke, Davis and Co. was employed;
(each 2 cc. when administered intramuscularly gives results comparable to 200—
250 grams of raw liver administered orally).
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germanin very well. At Sulzberger's suggestion I decided to
try liver injections as a prophylactic agent in cases of intolerance
to arsenicals.
Because of the great importance of this problem, it was decided
to investigate it on as many patients as possible. Recognizing
the many possibilities for error in this type of investigation, I
proceeded very cautiously in the selection of cases for this study.
At first the milder forms of arsenical intolerance were selected,
but as the investigation progressed and it was seen that the
procedure was not only harmless in all cases, but also apparently
useful in. some of them, I began to try it out on more serious
cases. As a result the entire group studied includes different
varieties and degrees of arsenical intolerance: 10 cases with
mild and severe gastrointestinal disturbances, 5 with pruritus,
5 with fixed eruptions, 2 with nitritoid crises, 11 with generalized
or localized erythemas with or without scaling, and 3 cases with
a history of exfoliative dermatitis, making a total of 36 cases.
Two methods were employed in using the liver extract as a prophylactic
measure. In the firat group comprising 10 cases the method was as follows As
800fl as the characteristic reaction of intolerance had been noticed once (or in
some eases several times), the patient underwent a physical examination includ-
ing a blood count, urine analysis, and in most cases, also a liver function test.
If the condition of the patient permitted, the injection of the offending arsenical
(in the same or smaller dosage) was repeated the next week or later. At this
time, however, the injection of the arsenical was preceded half an hour by an
intramuscularinjection of liver extract (1—2 cc.). If the symptoms of intolerance
reappeared after this treatment and were as pronounced as previously, the arseni-
cal in question and liver extract were discontinued temporarily, or in some cases
dropped completely. If the symptoms of intolerance were ameliorated or absent
after this treatment, the arsenical (in increased dosage) was readministered the
next week, preceded by a liver extract injection. In that manner a full course of
the arsenical injections would be given (dosages gradually increased) each time
preceded by liver-extract injections. After a rest period of 4—6 weeks, the
arsenical in question was renewed, sometimes with, and sometimes without the
addition of liver administration.
In the second group (comprising 20 cases), as soon as the fact of a characteristic
form of arsenical intolerance was established, the patient was thoroughly ex-
amined and the arsenical discontinued temporarily. The patient was then given
a course of liver extract injections (average 12 injections, given once to three times
a week). On completion of this course of liver, the arsenical was readministered
and given in the same way as in the first group—each time preceded by a liver
injection.
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TOTAL RESUI1FS
The results of the investigation of the value of liver as a pro-
phylactic measure in arsenical intolerance are given in tables
TABLE 2
(Analysis of table 1.) Value of liver in prevention of intolerance to arsenical8
NUMBER OF
CASES
ARSENICAL
PRECEDED
BY LIVER
EACR TIME
PUPABA-
TORY COURSE
OF LIVER
GIVEN
SAME DOSE
READ-
MINISTERED
SMAX.LRR
DOSE READ-
MINISTERED
Total number
Improved
Unimproved
36
24(66.6%)
12(33.3%)
16
13(81%)
3(19%)
20
11(55%)
9(45%)
23
12(52%)
11(48%)
13
12(92%)
1(8%)
TABLE 8
I?elation8hip between the results of preventive liver injections and the "time factors"
(time eta p8ing between the moment of appearance of sin8 of intolerance and the
moment of readministration of the arsenical with the help of liver)
TIME FACTORS TOTAL NUMBER IMPROVED UNIMPROVED
1—2 weeks 9 8 1
2—10 weeks 15 8 7
10 weeks—iS months 12 8 4
TABLE 4
(Anal ysi8 of table 1.) Value of liver in the prevention of various types of intolerance
to ar8enicale
SIGNS OF INTOLERANCE NIl OF IMPROVED UNIMPROVED
Total 36 24 12
Gastrointestinal disturbance, fever,
anemia 10 7 3
Pruritus without visible skin manifesta-
tions 5 5
Fixed eruption
Nitritoid crises
5
2
3
1
2
1
Generalized or localized erythema with
or without scaling
History of exfoliative dermatitis
11
8
8 3
3
1, 2, 3 and 4. The tables show that following liver therapy,
24 of 36 cases, or 66 per cent showed a definite improvement
in their intolerance.
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Relationship of resuU8 to methods
When the relationship of the results to the methods of therapy
is considered, it seems (see table 2) that the percentage of im-
proved cases was higher in the first group (81 per cent) than in
the second one (55 per cent).
This seems paradoxical because the patients of the second
group received more liver injections than those of the first group.
This is difficult to explain, except perhaps for the fact that the
second group included 3 cases with the history of exfoliative
dermatitis, a form of arsenical intolerance which is not easily
influenced. Moreover, several patients (inmates of the House
of Detention) of this group who were obviously averse to the
continuation of antisyphilitic therapy, evidently visibly ex-
aggerated their complaints and did not comply with the advice
of the attending physician, (regarding general hygiene, diet,
bowels, etc.).
Relationship of the results to the dosage of the arsenicals
Table 2 also gives us information about the relationship of
the dosage of the arsenicals to the results of the liver adminis-
tration. In most cases the dosage of the arsenical given when
liver therapy was instituted was exactly the same as when the
arsenical was previously given alone and was the dose which
had apparently been followed by the signs of intolerance. How-
ever, in some of the cases, because of the seriousness of the in-
tolerance, and the weakened condition of the patient, it was
considered safer to readminister the offending arsenical with
a smaller dose as a start, and increase the dosage gradually until
the dosage of the arsenical was often even larger than that at
which the signs of intolerance had previously appeared. Among
the cases in which the readministered arsenical was begun with
a smaller dosage, the number of improved cases was very large
(92 per cent). Among the cases in which the readministered ar-
senical was started with the same dosage the number of improved
cases was about the same as the number of unimproved ones.
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THE "TIME FACTORS" (s TABLE 3)
Under this term is understood the period of time which elapsed
from the moment the symptoms of intolerance appeared up to
the moment the same arsenical was readministered, supported
by liver injections (provided the manifestations of intolerance
had subsided sufficiently to permit the readministration of the
arsenical).
Subdivision of cases according to the "time factor" (see table )
It is well known that hypersensitivity in any patient may
spontaneously decrease and even disappear entirely, and there-
fore it was felt to be important to investigate the relationship
between the "time factors" and the apparent improvement of
the cases following liver therapy.
The cases were divided into three groups (see table 3): 1st
group (with "time factors" of 1—2 weeks); 2nd group (with
"time factors" of 2—10 weeks); 3rd group (with "time factors"
of 10 weeks—15 months).
It was found that there were many cases with a short time
factor (1—2 weeks) which responded very favorably to liver
therapy. In the 2nd group (2—10 weeks) there was a small
difference between the number of improved and unimproved
cases. In the 3rd group, there were more improved cases than
unimproved (2: 1).
We believe that with the possible exception of the 3rd group,
the time factor did not in any way influence the results of pre-
ventive liver administration in our cases.
VALUE OP LIVER IN THE PREVENTION OF VARIOUS TYPES OF
INTOLERANCE TO ARSENICALS
Table 4 shows the value of liver in the prevention of various
types of arsenical intolerance. It is interesting to note that all
cases of pruritus without visible skin manifestations responded
favorably to liver injections, while all cases with a history of an
exfoliative dermatitis were not influenced by liver administration.
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(a) Gastrointestinal disturbances. Fever, weakness, etc.
This group comprised 10 cases, which developed one or a com-
bination of several of the following symptoms: intense nausea,
dizziness, vomiting, headache, fainting, fever lasting 1—3 days,
marked weakness, low hemoglobin or low platelet count. The
symptoms appeared immediately or after an interval, but not
later than 24 hours after the administration of the offending
arsenical. In most cases the injection was repeated several
times and was followed each time by almost the same symptoms.
In 8 out of 9 cases these symptoms either were markedly ameli-
orated, or did not appear at all, when the liver was administered.
In the 3 others the liver extract injections did not have any in-
fluence whatever on the degree or character of the arsenical effects.
The following negative case is reported as an illustration.
Mrs. L. R., after receiving 18 injections of mapharsen began to complain of
intense nausea and dizziness after each injection (30 mgm.). The dose of maphar-
sen was gradually diminished to 5mgm., but the after effects still continued to
appear after each injection. Mapharsen was discontinued and a course of liver
extract (15 injections) was administered. A small dose of mapharsen (5 mgm.)
was administered after that (time factor 4 months). Nevertheless the above
mentioned after effects reappeared. A blood count taken at this time showed a
moderate anemia and a relative lymphoeytosis (47 per cent).
(b) Cases with pruritus without any visible skin manifestation8
Five of the patients were suffering from mild or intense itching,
which appeared 24—48 hours after each injection of either ma-
pharsen, of neoarsphenamine or of bismarsen respectively. The
pruritus was often accompanied by gastrointestinal disturbances,
such as nausea, vomiting, headache, generalized weakness and
so on.
With the exception of one case no preparatory course of liver
extract was given but the offending arsenical was readministered,
preceded each time by an injection of liver extract (1—2 cc.).
In most cases with the aid of a preceding liver injection, the ar-
senicals could be given without causing any pruritus, even though
the arsenical without preceding liver had only one week pre-
viously produced severe itching.
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In two cases the patients felt so well after a course of the ar-
senicals in combination with liver extract, that they were able
to receive the same arsenical without the help of liver extract.
In another case the pruritus reappeared promptly when the
liver therapy was discontinued.
The following case is characteristic of a good result.
V. M. bad latent syphilis, and was hypersensitive to silverarsphenamine,
mapharsen and bismarsen. He reacted with pruritus and gastrointestinal dis-
turbances even after 0.05 of bismarsen. The same dosage preceded by 1 cc. of
liver extract was repeated the next week. There were no after effects. The next
week 0.1 cc. of bismarsen was given, in the same manner. Fifteen bismarsen
injections were given, always preceded by liver extract (1—2 cc.). The patient
tolerated these injections well, Neither pruritus nor gastrointestinal disturb-
ances were noted.
(c) Fixed eruptions
The term signifies repeated appearances of a sharply localized
skin eruption, recurring in the same location (skin site), upon
repeated exposures to an offending agent (drug).
The influence of liver injections on the prevention of fixed
arsenical eruptions was studied in 5 cases. Two patients com-
plained that after each injection of mapharsen, they suffered
from headaches, "soreness" of both eyes, swelling and itching
of the eyelids. At the examination which took place 5 days
after the injection of mapharsen, one patient presented a slight
erythema of one eyelid, the other only a moderate conjunctivitis
in both eyes. After a preparatory course of liver extract injec-
tions (6—12 injections within 3—5 weeks) the same dose of maphar-
sen was readministered. When the patients were seen again,
5 days later, they expressed the same complaints and showed
about the same objective symptoms. The use of mapharsen
was discontinued in these cases.
On the other hand, a patient was observed who developed
swelling and erythema of the eyelids of both eyes, each time
about 24 hours after an injection of neoarsphenamine 0.15, or
mapharsen (10 and 5 mgm.). One week later he received 5
mgm. of mapharsen preceded by an injection of liver extract.
No untoward reaction developed. The dosage of mapharsen
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was gradually increased (5 mgm. weekly) until 55 mgni. was
reached, without any after effects. After the patient received
15 mapharsen injections each time preceded by liver, he began
to receive, a short time later, mapharsen without the liver ex-
tract. No after effects followed.
Another case in this series developed a dollar-sized, slightly
edematous, erythematous and scally, pruriginous patch on the
cheek after an injection of 0.1 of neoarsphenamine. The erup-
tion became more pronounced after each successive injection
(0.2—0.3). Neoarsphenamine was discontinued and a course of
liver extract injections was given (12). During the liver adminis-
tration, the pruritus disappeared and the eruption improved con-
siderably. After that, neoarsphenamine 0.1, 0.15, 0.2 was re-
newed, each time preceded by liver extract. The patch on the
cheek not only did not become aggravated after that, but dis-
appeared completely. Only after the last injection the patient
complained of mild pruritus at the site of the previous eruption.
One case in which the liver therapy gave satisfactory results
is somewhat complicated and must be mentioned in detail.
L. E., female, 47, was very sensitive to neoarsphenamine. She developed
redness, swelling, tenderness of both eyelids after each injection. Two years
later, a course of mapharsen injections was instituted. After the 6th and 7th
injections (30 mgm.) the patient developed eruptions on the eyelids, similar to
those above described. The same type of eruption reappeared 8 months later
when inapharsen (5 mgm.) was administered, preceded by liver extract injections.
Mapharsen was discontinued and a preparatory course of liver was administered
(12 injections, 1 cc. each). Mapharsen was tried again, but the patient still
showed the same reaction of a hypersensitivity to the drug. It was discontinued
and two courses of liver extract were given (30 injections, 1 cc. each). Follow-
ing this, (15 months after the intolerance to mapharsen began) the patient began
to receive ascending doses of mapharsen (5—20 mgm.) each time preceded by liver
(2 cc.). The patient reacted each time with a few small erythematous, non-
pruriginous 8pots on the eyelids, and the eruption was less pronounced each time,
in spite of the fact that the dosage of mapharsen was increased each time. She is
being treated with mapharsen now, and is very contented, while previous to the
liver therapy, she absolutely refused mapharaen injections.
This case demonstrates that liver administration may perhaps
be worthy of a longer trial in certain cases of fixed eruptions.
Among the five cases of fixed eruptions, there were three
in which the administration of liver extract was followed by
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amelioration or non-reappearance of a fixed arsenical eruption.
'Whether this was a result of liver administration, or only coin-
cidental, cannot be definitely decided, because it is known that the
specific local sensitivity of the skin may change spontaneously,
and the recurrences may become milder, or the eruption may not
reappear even when the use of the particular drag is continued
or renewed.
(d) Nit ritoid crises
Two cases were observed. One which could be considered
very mild, presented only reddening of the face and vomiting
immediately after an injection of neoarsphenamine 0.8 mgm.
The same dosage was administered the next week, preceded by
a liver extract injection (1 cc.). There were no after-effects
at the next 20 injections of arsphenamine (0.45—0.6) which were
always preceded by liver injections (2 cc.).
The other case presented a typical and marked nitritoid re-
action which occurred after 1.0 of tryparsamide. One half a
year later a course of 12 liver extract injections was ordered
(1—2 cc.) to be given twice a week. On completion of the
course, injections of tryparsamide were administered beginning
with 0.5. The patient tolerated these injections well and also
the one of 1.0, but when 1.25 was administered, the patient com-
plained of sudden weakness, nausea, and presented redness,
edema of face and a mild conjunctivitis. A few minutes later
she developed a localized urticaria like eruption, which was
followed later by a diffuse erythema of the whole body. The
eruption disappeared in 1—2 days.
(e) Generalized or localized erythematous or erythemato-scaly
eruptions (including urticaria)
This includes all patients with more or less benign cutaneous
reactions; among them were 3 with generalized maculo-papular
eruptions which were accompanied by some scaling, 7 with a
generalized or localized erythema, and one patient with urticaria.
Among these 11 cases there were 3 in which the prophylactic
injections of liver extract did not produce any change in the
VALUE OF ADMINISTRATION OF LIVER 439
patients' hypersensitivity to arsenicals. On the other hand, 2
cases presented some improvement, while 6 cases have shown
either a definite decrease of their clinical hypersensitivity to
arsenicals, or a complete disappearance of the hypersensitivity.
As an example one patient, who developed a generalized maculo-
papular eruption after 40 mgm. of mapharsen may be cited.
This man was so severely ill after the injection that he bad to remain in bed
for a few days. Mapharsen was readministered one week later (only 10 mgm.).
The patient reacted with fever, nausea and arthritic pains. The treatment of
this patient was recommeaced one week later, with ascending doses of mapharsen
(starting with 5 mgm.) preceded each time by a liver injection. In this manner
he received 15 injections of mapharsen and 15 injections of liver. There were
absolutely no after effects following the injections of mapharsen. In fact he felt
so completely well, that it was decided a short while later, to abandon the liver
extract injections. He received more than 40 mapharsen injections (dosage
40—60 xngm.), (without liver extract injections) without any after effects.
In another case, however, a recurrence of generalized erythema
with pruritus reappeared promptly, when mapharsen was given
once without the precaution of a preceding liver injection. As
soon as liver therapy was again instituted, the patient again
began to tolerate the mapharsen perfectly and no untoward
effects resulted from the continuation of mapharsen treatment
as long as given in conjunction with liver.
In this series it is admittedly difficult to interpret the exact
relationship between the injections of liver administration and
the changes in the hypersensitivity to arsenicals. It is un-
doubtedly possible that these changes occurred spontaneously
and were only coincidental with the liver administration. How-
ever, the time factors also have to be considered and these speak
somewhat in favor of the beneficial effects of the liver admin-
istration.
(f) Exfoliative dermatitis
Three cases were observed. In all of these a history of an
exfoliative dermatitis, following arsenotherapy, was present.
A very small dosage of another arsenical was tried in these cases.
The patients all showed a marked hypersensitivity also to the
new preparation. All arsenicals were discontinued, and a pre-
paratory course of liver extract was given, after which the first
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offending arsenical (same dosage) was administered again, pre-
ceded by an injection of liver extract. All these patients reacted
again with marked after effects. One of these negative cases
may be cited in more detail.
W. W. developed an exfoliative dermatitis with a generalized alopecia after
treatment with neoarsphenamine. Four years later a email dose of mapharsen
was given (5 mgm.). Two to three hours later a generalized erythema with in-
tense pruritus and a feeling of swelling and internal heat developed. Eight
months later the patient received a preparatory -course of liver extract injections
(12 injections 2 cc.). Following that the same dosage of mapharsen (5 mgm.)
was again tried. The same day the patient developed a reaction similar to that
described above.
This case and the two others prove definitely that liver ad-
ministrations did not prevent the reaction of hypersensitivity in
patients who had developed an exfoliative dermatitis due to arsenicals.
(g) Liver in the treatment of existing manifestations due to arsenical
intolerance (see tables 5 and 6)
Thus far only prophylaxis has been discussed. The value
of liver in the treatment of the after-effects of arsenical intolerance
was investigated by some German authors in 1929 and found to
be very promising. Spiethof (25), Milbradt (14), Fulst and
Fellner (8) found this form of treatment to be of great help in
the amelioration of symptoms of arsphenamine toxicoses.
The effect of liver therapy was investigated in 15 of our cases
which presented various kinds Of after-effects following arseno-
therapy. (See table 5.) The duration of the after-effects of
intolerance varied from 4 weeks to 4 years
Some patients began to have treatment with liver soon after
the after-effects appeared; others began to receive liver therapy
only after many months of ailing, after many other methods of
treatment failed. The injections of liver were given into the
gluteal muscles 1—2 times weekly. The average course con-
sisted of about 15 injections. The initial dose was —1 cc.,
which was gradually increased to 2—2k cc.
With the exception of one case, all patients felt better mentally
and physically, after only a few injections were given. Increased
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appetite, a feeling of returning strength, improvement of mood
and disappearance of nausea and weakness, are changes that
were reported by almost all of these patIents, including those at
the House of Detention, who were usually very uncooperative
and objected to any kind of "shots." The improvement in the
blood counts in many of our cases is mentioned elsewhere in
this paper. (See tables 8 and 9.)
In order to give a detailed report on the improvement of the
treated cases, it was necessary to divide these in 4 groups, ac-
cording to the most important signs of intolerance. (See table 6.)
TABLE 6
(Analysis of table 5.) Therapeutic effect of liver in the treatment of different type8 of
after-effects of exi8ting intolerance to ar8enicals
SIGHS OF INIOLERA1qCS
IWM-
ERR OP
CASES
CORE
OR
MARK-
PRIM-
PROVE-
RENT
BLIGHT
ZR-
PROVE-
RENT
02q111-
PROVED
AVER-
AGE
BEE OF
INIEC-
TIONS
AVERAGE
D7EATION
OW APTER-
EFFECTS
BEFORE
LIVER
THERAPY
AVERAGE
DEATION
OF TREAT-
RENT WITH
LIVER
Vomiting, weakness, ane-
mia, dizziness 4 2 2 12 5 wke. 4 wks.
Long-standing pruritus.... 5 4 1 86 17 moe. 5 mos.
Erythematous and scaly
eruptions 3 2 1 11 7 wks. 6 wks.
Exudative arsphenamine
dermatitis or exfoliative
dermatitis 3 2 1 16 12 wks. 7 wks.
Total 15 10 4 1
Group 1 consisted of 4 patients, who complained of a feeling
of weakness, loss of appetite and nausea. Some also complained
of dizziness, often vomiting. The duration of these symptoms
was about five weeks. These patients received an average of
12 injections and their condition improved in about 4 weeks.
Two of these patients showed, subsequent to liver therapy, a
marked increase in the number of red blood cells and platelets.
Group 2 comprised 5 cases with long standing pruritus. The
average duration of their condition was about 17 months. The
itching was so stubborn that it failed to improve after many
different methods of therapy were tried. While under liver
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therapy (and perhaps due to this treatment) the pruritus dis-
appeared completely in 4 cases and was ameliorated in one.
However, these patients were treated for a much longer time
than the previous group (average 5 months), and received an
average of 36 injections of liver. One patient, J. B., who 4 years
before had developed a moderate form of persistent pruritus,
was treated at one time or another, with sodium thiosulphate,
autohemo therapy, and generalized Roentgen radiation. All
these failed to ameliorate his condition. He improved after
3 courses of liver injections. Another case, N. S., who suffered
from pruritus of 2 years' duration, improved somewhat while
under treatment with liver (30 injections). When the patient
returned, after an absence of 6 months, be reported that he
was feeling perfectly well and the pruritus was completely cured.
Group 3 included 3 cases presenting a generalized or localized
erythema with scaling. Two cases cleared up completely, one
improved somewhat after an average of 11 injections (average
duration of treatment was 6 weeks). One of these cases, W. S.,
presented an erythematous, scaly eruption on one leg, which
was very pruritic and persisted for 6 weeks. Liver injections
were instituted. After 2 injections the patient stated that
the pruritus was diminishing. The eruption disappeared com-
pletely in 2 weeks, after 8 injections of liver.
The 4th group included the most important and serious com-
plications of arsenotherapy and comprised 3 cases of typical
severe arsphenamine dermatitis. Two of these may be con-
sidered to have responded well to liver therapy. One of them
developed a generalized papulo-vesicular dermatitis with many
crusted lesions after mapharsen therapy. This condition was
treated with injections of sodium thiosuiphate and calcium
gluconate orally, for five weeks. The patient did not show any
inprovement. As soon as liver extract injections were instituted,
the eruption began to improve rapidly. It cleared up entirely
in 2 months, after 15 injections. Following these, the patient
received 10 bismuth salicylate injections, after which the eruption
reappeared in some spots. The eruption is once again showing
improvement while the patient is receiving liver injections.
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The case which did not respond to liver therapy presented
a generalized papulo-vesicular crusted eruption, covering almost
the entire body. Some of the lesions coalesced, forming large
flat infiltrated plaques. The histologic examination confirmed
the diagnosis of arsenical dermatitis. This patient was given 8
injections of liver within 3 weeks. Not only the cutaneous
manifestations, but even his general condition did not show any
signs of improvement following the liver therapy.
LIVER PUNCTON TESTS
Liver function tests were performed on 34 of our cases at the
time when the reaction of hypersensitivity to the arsenicals was
most pronounced. In a few cases the performance of the tests
TABLE 7
Comparison between icteric index in cases hypersensitive and ca8es non-h yper-
sensitive to mapharsen
Number of cases sensitive to mapharsen 20
Increased icterus index (10—15) in 6 cases 30%
Number of cases non-sensitive to mapharsen 20
Increased icterus index (10—15) in 8 oases 15%
was inadvertently postponed until some time later. No arsen-
icals however, were administered in the interval.
The direct Van den Bergh tests, which were performed on a
large majority of these cases were negative in all. Only a few
showed an increase in the serum bilirubin. The icteric index
was usually normal but in 8 out of 34 cases or in about 23 per
cent there was some increase (10—15). Although an icteric
index above 10 and lower than 15 does not point to liver damage,
it does however warn that these patients should be watched care-
fully (Mattice, 33).
In order to determine the difference in the icteric indices
in patients sensitive and non-sensitive to arsenicals we selected
among dispensary cases those which were treated and were
proven to be clinically hypersensitive to mapharsen. There
were 20 of £hese. We also chose from our previous records
(1) 20 cases which were treated with mapharsen and were not
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clinically hypersensitive to the drug. We compared the icteric
indices in both groups. The results were as follows: In the
first group (hypersensitive to mapharsen) there were 8 cases
out of 20 (30 per cent) which showed an increase in the icteric
index (10—15). In the second group (non-hypersensitive to
mapharsen), there were only 3 such cases (15 per cent). In
other words in these very small series there was twice as great
a percentage of cases with an increased icteric index among
patients hypersensitive to mapharsen, as there was in the non-
hypersensitive group. It seems that confirmation of such find-
ings in a larger series may point to the probability that there is
some relationship between sensitivity to arsenicals and dysfunc-
tion of the liver.
THE INFLUENCE OF LIVER THERAPY ON THE HEMATOLOGIC
FINDINGS (BEE TABLES 8 AND 9)
Prompt and striking increase in the number of red and white
blood-cells and of the platelets as a result of liver therapy is
reported by Murphy, Connery and Goldwater and others. In
studying this phase of the subject, blood counts were performed
on almost all patients in this study (in 43 out of 48 cases). The
blood count was taken before the liver treatment was begun
and was usually repeated immediately thereafter, or a short
while after the course of liver injections was completed. One
group of cases presented, following arsenotherapy, a normal
or unchanged blood picture. In 24 cases however, there were
definite changes. Some presented a low hemoglobin, a low red
or white blood cell count, or a decrease in the number of platelets,
an increase in the percentage of lymphocytes and a relative
decrease in the polynuclears.
All of these 24 cases were treated with liver and the results
investigated. In only two the blood counts did not improve.
(In one of these cases the platelet count even decreased.) In
4 others the blood count was not repeated, following the com-
pletion of the liver therapy, so that its influence could not be
ascertained. The other 18 however, showed a definite improve-
ment in the blood count following liver therapy. (See figure 8.)
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In order to prove that these blood changes were due to liver
therapy and not to spontaneous improvement of the blood pic-
ture, the changes in the blood count in these cases were compared
with those in patients who were not treated with liver.
Patients, some of whom were absent from the clinic for some
time during which they received no treatment whatsoever, were
TABLE 8
Possible influence of liver therapy on the blood count in cases intolerant to arsenical8
Total number of cases in which blood studies were performed 43
Number of cases in which there were definite regressive changes fol-
towing arsenic therapy 24
Number of cases (out of 24) in which there was a definite improvement
in the blood count following liver therapy 18
Average increase in the hemoglobin 14%
Average increase in the number of R.B.C 697,000
Average increase in the number of platelets 80,000
Average number of liver injections 16
Average time elapsing between blood count taken before liver treat-
ment and blood count taken after liver treatment 9 wks.
TABLE 9
Comparison bekveen the changes in the blood counts in cases treated and cases not
treated with liver
Nm&EER
OF CASES
AVEBIGN
INCREASE
IN E.E.C.
AVERAOSI
INCREASE
IN NUMBER
OF PLATE
LETS
TIME ZN
wmcH
CNANGES
OCCURRED
Cases in which the blood count improved
following liver therapy
Cases in which the blood count improved
spontaneously
16
5
897,000
160,000
80 000
84,000
9 wks.
25wks.
chosen as controls. Blood counts were taken before the patient
left the clinic and repeated when he returned. The average
changes in the blood counts in these cases which received no liver
were compared to those in cases treated with liver (see figure 9).
We see from this table that the average increase in platelets was
about the same in both groups. However, in striking contrast
to this, the average increase in the number of the red blood cells
in cases treated with liver was more than times greater than
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the average increase in cases not treated with liver. The time
required for these changes was about 2 times less in the group
treated with liver, than in the group where liver was not used.
We can say, therefore, that the improvement in the blood
counts, in cases treated with liver is more pronounced and faster
than in cases where liver was not used; and that liver injections
are of decided benefit in improving the blood picture of patients
under arsenotherapy.
IJNTOWXRD REACTIONS OM LIVER ADMINISTRATION
A few authors (Metzger (13), Held and Goldbloom (9), Roover
(19), Criep (4)) have reported cases which developed attacks
of bronchiai asthma, angioneurotic edemas, or "anaphylactic" re-
actions after injections of liver extract. However, most of
the investigators stress the very small number of after-effects
following liver extract injections. Connery and Goldwater (3)
did not see any important after-effects in their cases (50). Mur-
phy (16) also reports very few reactions (except an occasional
urticaria, fainting or fever). In our cases, we did not see any
after-effects whatsoever with the possible exception of one patient
who developed an intense pain in the leg after an injection of
liver extract. The pain lasted two hours.
CONCLUSIONS
1. The results of the investigation of the efkct of injections
of liver extract, as prophylactic and therapeutic agents in 48
cases of intolerance to arsenicals are presented.
2. Liver extract injections were followed in many cases by
definite favorable progressive changes in the blood counts, and
improvement of the patients' general condition.
3. Liver extract is a useful therapeutic agent in some cases
suffering from manifestations due to intolerance to arsenicals.
4. The results of our investigation of the prophylactic effect
in arsenical intolerance seem to indicate that liver extract in-
jections may be of some value in preventing pruritus, and in
preventing or ameliorating intestinal disturbances, erythema with
scaling as well as fixed eruptions, but are of no prophylactic
value in preventing recurrence of exfoliative dermatitis.
448 nm JOURNAL OF INVESTIGATIVE DERMATOLOGY
5. Our series is too small to permit final conclusions on the
value of liver extract as a prophylactic agent in preventing
manifestations of arsenical intolerance. However, in view of
the results of our investigation, we believe that this problem is
worthy of further and more extensive study, including for ex-
ample the possible advantage of increasing the dosage of liver.
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